News
Becky Davis of Charles River Associates predicts that an influx of new and oral GLP-1 drugs, along with pricing pressures ...
At this year’s Asembia Specialty Pharmacy Summit in Las Vegas, Managed Healthcare Executive spoke with John Beardsley, senior ...
The victims of intimate partner violence were found to have more menopause symptoms, according to the results of a Turkish ...
Asembia Specialty Pharmacy Summit, Becky Davis, principal at Charles River Associates, discussed how employer-based insurance ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
An already approved cancer drug, Yervoy (ipilimumab), improved lung repair ability in a study of mice with idiopathic ...
The actor expressed some regret as well as gratitude in talking about the death of his 33-year-old son from a rare form of ...
Managed Healthcare Executive asked several experts in healthcare and managed care to share the trends they think the industry ...
Kathi Henson, senior vice president of patient services, nursing and quality at Orsini, spoke with MHE editors at this year’s Asembia Specialty Pharmacy Summit in Las Vegas about how analytics and AI ...
Asembia Specialty Pharmacy Summit in Las Vegas, John Beardsley, senior vice president of corporate business development at CoverMyMeds, and Fauzea Husain, vice president of public policy at McKesson, ...
Fran Gregory, PharmD, MBA, VP of emerging therapies at Cardinal Health, talks about the importance of market access strategies in the cell and gene therapy space.
Joe DePinto from McKesson discussed the challenges facing cell and gene therapies, particularly around reimbursement, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results